According to our previous study using a panel of breast cancer cell lines [2], HCCR-1 was highly expressed in breast cancer cell lines with high HER2 overexpression, with some exceptions, that have a mutated p53 and express ER/PR [10-13]. This evidence concerns the gene ERBB2 and breast carcinoma.